Biotech · Private company · Bothell, WA, US
PharmaIN
Track this companyFree. Adds PharmaIN to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- PHIN-214 Subcutaneous injectionPhase 1 · Cirrhosis, LiverClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver CirrhoticsPHASE1 · RECRUITING · started Jan 3, 2022ClinicalTrials.gov NCT05490888 · fetched Nov 12, 2026
NIH awards3
- Subcutaneous Drug Development for Portal Hypertension AscitesFiscal year 2025 · $2.6MNIH RePORTER 5R44DK103553-06 · fetched Nov 12, 2026
- Subcutaneous Drug Development for Portal Hypertension AscitesFiscal year 2024 · $2.1MNIH RePORTER 2R44DK103553-05 · fetched Nov 12, 2026
- Development of an immunomodulating peptide as a therapy for osteosarcoma in canine and humanFiscal year 2024 · $995.1KNIH RePORTER 5R44CA278570-02 · fetched Nov 12, 2026